文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 电子/电路 > Serratiopeptidase A systematic review of the existing evidence
侵权投诉

Serratiopeptidase A systematic review of the existing evidence

REVIEW

InternationalJournalofSurgery11(2013)209e217

ContentslistsavailableatSciVerseScienceDirect

InternationalJournalofSurgery

journalhomepage:doc.guandang.net

Serratiopeptidase A systematic review of the existing evidence

eijs.com

Review

Serratiopeptidase:Asystematicreviewoftheexistingevidence

ShivaniBhagat*,MonikaAgarwal,VandanaRoy

DepartmentofPharmacology,MaulanaAzadMedicalCollege(MAMC),FirstFloor,PathologyBlock,NewDelhi110002,India

articleinfo

Articlehistory:

Received20July2012Receivedinrevisedform8December2012

Accepted26January2013

Availableonline1February2013Keywords:

SerratiopeptidaseSerrapeptase

SerratiopeptidaseProteolyticenzymesPharmacokineticsPharmacodynamics

Anti-in ammatoryagentsDanzen

SerratiapeptaseSerralysin

Adversedrugreactions

abstract

Background:Serratiopeptidaseisaproteolyticenzymeprescribedinvariousspecialitieslikesurgery,orthopaedics,otorhinolaryngology,gynaecologyanddentistryforitsanti-in ammatory,anti-edemicandanalgesiceffects.Someanecdotalreportssuggestittopossessanti-atheroscleroticeffectsalso,duetoits brinolyticandcaseinolyticproperties.Despitebeingwidelyusedtherearefewpublishedstudiesregardingitsef cacy.Thus,evidenceregardingitsclinicalutilityisneeded.

Objective:Toevaluatetheexistingevidenceregardingef cacyandsafetyofSerratiopeptidaseinclinicalpractice.

Evidenceacquisition:AsystematicreviewofallthepublishedarticlesofSerratiopeptidaseusingCochraneLibrary,PubMed,MEDLINE,ClinicalTrials.gov,Google,Dogpileandamanualsearchofbibliographieswasconductedfrom1stMay2011till15thJuly2012.Furtheremailsweresenttoalltheleadingpharma-ceuticalswhoaremanufacturingthisenzymepreparationforanyadditionalinformation.AllstudiesrelatedtoSerratiopeptidasewhichincludedRandomisedcontrolledtrials(RCTs),meta-analysisofRCTs,placebo-controlled,single-blind,double-blind,openlabel,prospectivetrialsaswellaspreclinicalstudieswerescreenedandanalysed.Thescienti ccredibilityofthestudieswasgradedaccordingtotheScottishIntercollegiateGuidelinesNetwork(SIGN)gradingchecklist.Atotalof24studiesonclinicalef cacyofSerratiopeptidasemettheinclusioncriteria.

Evidencesynthesis:SerratiopeptidasesearchonCochranelibraryrevealed16resultsamongwhich9wereCochraneCentralRegisterofControlledTrials2011,issue4studiesand7wereCochraneCentralRegisterofControlledtrials2012,issue3studies.Ofthese16results,11wereRCTsonef cacyofSerratiopepti-dase.PubMedsearchalsorevealed74resultswhichshowed16Clinicaltrials,outofwhich9wereRCTsrelatedtoSerratiopeptidase.Bandolieronlineedition(retrievedon1/5/2011)showedareview’Serra-tiopeptidase- ndingtheevidence’whichincluded9RCTs.TheevidencesupportingtheuseofSerra-tiopeptidaseasanti-in ammatoryandanalgesicagentisbasedonclinicalstudieswhichareofpoormethodology.OnlyfewRCTs,whichareusuallyplacebocontrol,withasmallsamplesizearethere.Thedoseanddurationoftreatmentwasnotspeci edinsomestudies,andtheoutcomeofthestudywasnotclearlyde nedinafew.DataonthesafetyandtolerabilityofSerratiopeptidaseislackinginthesestudies.Limitations:Athoroughsearchofliteraturewasdonetoincludealltherelevantstudiesbutwemayhaveunknowinglymissedafewofthosestudieswhichhavenotbeenpublishedorregisteredwithanyofthesesearchengines.Theclinicalevidenceobtainedhavebeengradedaccordingtothe"ScottishIntercollegiateGradingNetwork"checklistbytwoseparatereviewersandthencoordinatedtogethertogivethe nalgrading.Anydisagreementbetweenthetworeviewerswasresolvedbydiscussionwiththethirdreviewer.Thiswasdonetominimisebiasbutstilltheriskofbiascannotbecompletelyruledout.Conclusion:Serratiopeptidaseisbeingusedinmanyclinicalspecialitiesforitsanti-in ammatory,anti-edemicandanalgesiceffects.Itisevenbeingpromotedasahealthsupplementtopreventcardiovascularmorbidity.Theexistingscienti cevidenceforSerratiopeptidaseisinsuf cienttosupportitsuseasananalgesicandhealthsupplement.Thedataonlong-termsafetyofthisenzymeislacking.Evidencebasedrecommendationsontheanalgesic,anti-atheroscleroticef cacy,safetyandtolerabilityofSerratio-peptidaseareneeded.

Ó2013SurgicalAssociatesLtd.PublishedbyElsevierLtd.Allrightsreserved.

1.Introduction

*Correspondingauthor.Tel.:þ917838636564(mobile).E-mailaddress:drshivani.dmc@gmail.com(S.

Serratiopeptidase A systematic review of the existing evidence

Bhagat).

Serratiopeptidase(SerratiaE-15proteasealsoknownasserral-ysin/serratia-protease/serrapeptase)isaproteolyticenzymethat

1743-9191/$eseefrontmatterÓ2013SurgicalAssociatesLtd.PublishedbyElsevierLtd.Allrightsreserved.doc.guandang.net

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email